Sunshine Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $9,417 | $9,410 | $8,901 | $9,594 |
Gross Profit | 3,073 | 3,422 | 2,730 | 3,093 |
EBITDA | -925 | -1,907 | -1,155 | |
EBIT | -1,021 | -1,980 | -1,219 | |
Net Income | -883 | -1,770 | -1,180 | -2,158 |
Net Change In Cash | 9,417 | 9,410 | 8,901 | 9,594 |
Free Cash Flow | -735 | -1,823 | -1,925 | -3,846 |
Cash | 9,306 | 10,305 | 8,124 | 9,686 |
Basic Shares | 4,651 | 224 | 2,703 | 2,580 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $34,874 | $24,093 | $4,346 | $228 |
Gross Profit | 10,670 | 8,339 | 1,697 | 110 |
EBITDA | -5,154 | -3,824 | -26,447 | -12,095 |
EBIT | -5,377 | -3,973 | -26,472 | -12,107 |
Net Income | -5,134 | -4,506 | -26,744 | -12,436 |
Net Change In Cash | 34,874 | 24,093 | 4,346 | 228 |
Free Cash Flow | -14,852 | -9,563 | -5,553 | -1,829 |
Cash | 9,686 | 16,292 | 21,826 | 2,045 |
Basic Shares | 701 | 12 | 7 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.19 |
2025-06-30 | -$0.39 |
2025-03-31 | -$0.83 |
2024-09-30 | -$0.94 |
